2 growing ASX dividend shares analysts rate as buys

These dividend shares are growing at a solid rate…
The post 2 growing ASX dividend shares analysts rate as buys appeared first on The Motley Fool Australia. –

If you’re on the lookout for some dividend shares to add to your portfolio, then you may want to check out the ones listed below.

Here’s why these ASX dividend shares could be in the buy zone:

Aventus Group (ASX: AVN)

The first ASX dividend share to look at is Aventus. It is a fully integrated owner, manager, and developer of large format retail centres in Australia.

At the last count, Aventus had a portfolio of 20 centres valued at $2.2 billion and spanning 536,000m2 in gross leasable area. It also has a diverse tenant base of 593 quality tenancies, with national retailers representing 87% of the total portfolio.

Demand for the company’s tenancies has remained strong during the pandemic, underpinning strong rental collections. This led to a 6.5% increase in funds from operations (FFO) to $55.9 million during the first half. In addition, a recent update reveals that the valuation of its properties has increased 12% since then.

One broker that is very positive on the company is Goldman Sachs. It currently has a buy rating and $3.27 price target on its shares. This compares to the latest Aventus share price of $3.15.

Goldman is also forecasting yields of approximately 5.4%, 6.1%, and 6.6%, respectively, between FY 2021 and FY 2023.

Integral Diagnostics Ltd (ASX: IDX)

Another ASX dividend share to look at is Integral Diagnostics. It is a medical imaging service provider that operates from a total of 72 radiology clinics across the country.

As with Aventus, Integral Diagnostics has been a solid performer in FY 2021. For example, during the first half of FY 2021, it reported a 29.5% increase in revenue to $170.7 million and a 61.1% jump in net profit after tax to $23.2 million.

Goldman Sachs is also positive on Integral Diagnostics and has a buy rating and $5.50 price target on its shares. The broker believes it is a well-run business in an attractive industry, with a relatively secure volume profile of mid/high single digit growth, and a clear path for further growth through brownfield and M&A activities.

Its analysts are forecasting fully franked dividends per share of 11 cents, 14 cents, and 15 cents between FY 2021 and FY 2023. Based on the latest Integral Diagnostics share price of $5.36, this will mean yields of 2%, 2.6%, and 2.8%, respectively.

The post 2 growing ASX dividend shares analysts rate as buys appeared first on The Motley Fool Australia.

These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

Returns As of 15th February 2021

More reading

2 All Ords shares this broker rates as buys

Top brokers name 3 ASX dividend shares to buy today

2 top ASX dividend shares for income investors

Here are 3 ASX 200 shares that were on the move today

Why Appen, Aventus, HomeCo Daily Needs, & Ramelius are dropping

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended AVENTUS RE UNIT and Integral Diagnostics Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!